Price $71.82 |
Market Cap
187.04B
|
Sector Health Care |
Div. Growth
2.20%
|
|
P/E
48.7
|
P/B
5.85
|
P/S
4.61
|
Dividend %
2.70%
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
7.38M
|
FCF
0.0
|
|
Op. Margin
12.30%
|
Net Margin
3.30%
|
ROE
3.90%
|
ROI
8.70%
|
|
ROA
1.50%
|
EPS Growth
-72.80%
|
Current Ratio
1.3
|
Debt/Equity
62.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| American Renal Associates Hold (ARA) | $18.27 | - | - | 702.9M | Strong Buy |
| Procyon Corp (PCYN) | $0.26 | - | - | 2.3M | Strong Buy |
| Neurometrix Inc (NURO) | $1.26 | - | - | 9.9M | Strong Buy |
| Biostem Technologies Inc (BSEM) | $4.35 | - | - | 37.2M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.29 | - | - | 39.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
